7QPM

Discovery of Lu AF11167, a Phosphodiesterase 10A inhibitor clinical candidate

7QPM の概要

• エントリーDOI: 10.2210/pdb7qpm/pdb
• 分子名称: cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A, 5,7-dimethyl-2-[(1-methyl-4-phenyl-imidazol-2-yl)sulfanylmethyl]imidazo[1,2-a]pyrimidine, ZINC ION, ... (5 entities in total)
• 機能のキーワード: phosphodiesterase, pde, pde10a, schizophrenia, basal ganglia disorders, hydrolase
• 由来する生物種: Homo sapiens (human)
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 80131.40

構造登録者

Leonard, P.M.,Langgard, M. (登録日: 2022-01-05, 公開日: 2023-04-19, 最終更新日: 2024-02-07)

• 主引用文献: Kehler, J.,Kilburn, J.P.,Langgard, M.,Christoffersen, C.T.,Ritzen, A.,Marigo, M.,Jessing, M.,Bundgaard, C.,Puschl, A.,Feigin, K.,Nielsen, J.; Discovery of Lu AF11167, a Phosphodiesterase 10A inhibitor clinical candidate; To Be Published,

実験手法

X-RAY DIFFRACTION (2.4 Å)